{
    "Trade/Device Name(s)": [
        "ALP IFCC Gen.2",
        "ALP2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K171080",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033185"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJE"
    ],
    "Summary Letter Date": "April 10, 2017",
    "Summary Letter Received Date": "April 11, 2017",
    "Submission Date": "March 31, 2017",
    "Regulation Number(s)": [
        "21CFR862.1050"
    ],
    "Regulation Name(s)": [
        "Alkaline phosphatase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Alkaline phosphatase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "COBAS INTEGRA 400 plus"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Absorbance measurement"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche ALP IFCC Gen.2 colorimetric reagent for quantitative measurement of alkaline phosphatase in human serum and plasma",
    "Indications for Use Summary": "In vitro test intended for the quantitative determination of the catalytic activity of alkaline phosphatase in human serum and plasma on COBAS INTEGRA systems, used for diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases",
    "fda_folder": "Clinical Chemistry"
}